Psychedelic Therapy After the Executive Order: Now What?

As psychedelic therapies gain visibility, clinicians are increasingly asked to interpret clinical research, evolving policy, and growing patient interest. This session provides a balanced, current view of the field, including a patient story that illustrates the lived experience of treatment. A targeted policy update focusing on what is known today and how existing frameworks may influence clinical practice in the immediate term. As well as a multidisciplinary panel of experts who will discuss the current state of psychedelics, offering practical insight to help clinicians navigate this evolving area of mental health care.